封面
市場調查報告書
商品編碼
2127903

乳房攝影診斷AI市場規模、佔有率、成長、全球產業分析、區域洞察,2026-2034年預測

AI in Breast Imaging Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034

出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 164 Pages | 商品交期: 2-3個工作天內

價格

人工智慧在乳房攝影診斷市場成長要素

由於人工智慧在乳癌篩檢中的應用日益廣泛、對早期疾病檢測的需求不斷成長,以及放射科醫生面臨日益繁重的影像工作量,全球乳房攝影影像人工智慧市場正經歷快速成長。報告顯示,2025年全球乳房攝影人工智慧市場規模為8.425億美元。預計該市場將從2026年的10.906億美元成長至2034年的86億美元,預測期內CAGR為29.45%。北美地區在2025年佔據市場主導地位,市場佔有率達41.99%,這主要得益於數位乳房X光攝影的普及、人工智慧驅動的診斷工作流程、有利的法規核准以及對醫療技術的大力投資。

乳房攝影影像人工智慧技術涵蓋先進的軟體解決方案及相關服務,透過提升病灶檢出率、乳房密度評估、工作流程優先排序和報告準確性,為乳房X光攝影、數位乳房斷層合成(DBT)、乳房超音波和磁振造影(MRI)提供支援。乳癌篩檢率的提高以及對更快、更準確診斷的需求不斷成長,持續推動市場擴張。

市場定義和範圍

人工智慧在乳房攝影影像領域的應用,將機器學習、電腦視覺和深度學習演算法整合到乳房攝影影像工作流程中,以提高診斷準確性和臨床效率。這些人工智慧解決方案能夠幫助放射科醫師檢測可疑病灶、評估緻密乳房組織、優先處理高風險病例並減少假陰性結果。

該市場涵蓋人工智慧軟體、實施和支援服務、雲端、本地部署和混合部署模式,以及電腦視覺、機器學習和自然語言處理等技術。其應用實例包括癌症檢測和分流、乳房密度評估、工作流程優先排序、報告生成支援以及醫院、影像中心、乳癌篩檢機構和研究機構的風險分層。

市場動態

促進因素

乳癌早期檢測日益成長的需求是市場成長的主要驅動力。乳癌率的上升、全國篩檢計畫的擴展以及對更早發現可治療癌症的需求,正促使醫院和影像中心採用人工智慧驅動的診斷工具。人工智慧透過識別細微異常、減少漏診並提高篩檢的整體效率,進而提昇放射科醫師的工作效率。

趨勢

一個關鍵的市場趨勢是,人工智慧驅動的診斷技術正日益普及,並被整合到乳房X光攝影、數位乳房斷層合成(DBT)、超音波和磁振造影(MRI)的工作流程中。人工智慧解決方案的功能已不再局限於病灶檢測,而是擴展到乳房密度評估、工作流程最佳化和個人化風險預測等領域。越來越多的法規核准和臨床實踐中成功的案例研究進一步加速這些技術在醫療保健系統中的應用。

阻礙因素

高昂的實施成本仍是限制市場發展的主要因素。實施人工智慧需要投資於與PACS/RIS系統的整合、雲端基礎設施、網路安全、工作流程重新設計、軟體維護以及放射科醫生培訓。有限的保險償付政策和高昂的實施成本繼續阻礙小規模醫療機構採用人工智慧技術。

機會

人工智慧驅動的3D乳房斷層合成(DBT)技術的廣泛應用帶來了巨大的成長機會。隨著醫療機構擴大利用DBT來改善乳房組織的可視化效果,對能夠分析大量3D影像資料的人工智慧工具的需求也迅速成長。人工智慧驅動的DBT技術不僅提高了診斷準確率,還能同時減少放射科醫師解讀影像所需的時間。

課題

高品質標註影像資料集的匱乏仍然是業界面臨的最大挑戰之一。開發精準的人工智慧演算法需要大量經過臨床驗證、專家檢驗的乳房X光攝影、超音波、MRI和DBT資料集,這使得模型開發極為耗時耗力。

細分分析

依組件分類,到2025年,軟體領域成為市場成長的主要驅動力,這主要得益於PACS、雲端系統以及與乳房X光攝影工作站整合的AI診斷平台的廣泛應用。隨著實施和諮詢需求的成長,服務領域預計也將保持穩定成長。

就部署方式而言,基於雲端的部署方式憑藉擴充性、減少基礎設施投資、集中式軟體更新以及易於在企業內部署等優勢,引領了市場。

從技術角度來看,電腦視覺主導了市場。這是因為它在分析乳房X光攝影、數位乳房斷層合成成像(DBT)、超音波和磁振造影(MRI)影像以進行癌症檢測和病灶識別方面發揮著非常重要的作用。

依影像方式分類,乳房X光攝影和數位乳房斷層合成(DBT)佔據了最大的市場佔有率,因為它們廣泛用於常規乳癌篩檢計劃中。

就應用而言,癌症檢測和分診仍然是主要領域,因為越來越多的臨床證據表明,人工智慧可以提高癌症檢測率,同時減輕放射科醫生的工作。

依最終用戶分類,醫院和醫療保健系統佔據市場主導。這主要歸功於這些機構進行的大量診斷成像工作、其先進的數位基礎設施以及與人工智慧解決方案供應商不斷擴大的合作關係。

區域分析

預計北美將引領全球乳房攝影市場,到2025年市場規模將達到3.538億美元,主要得益於人工智慧乳房X光乳房X光攝影和數位乳房斷層合成技術的廣泛應用、先進的醫療基礎設施以及美國食品藥物管理局(FDA)的積極核准。歐洲預計將實現強勁成長,這主要得益於全國範圍內系統性篩檢計畫的實施以及人工智慧診斷技術法規核准範圍的擴大。亞太地區主導將實現快速成長,這主要受中國、印度和日本乳癌防治意識的提高、診斷基礎設施的改善以及對人工智慧醫學影像技術投資的增加所推動。拉丁美洲以及中東和非洲地區預計將保持穩定成長,因為各國政府將加強癌症篩檢計畫並推動醫療現代化。

本報告對全球乳癌影像人工智慧市場進行了全面分析,涵蓋了2025年、2026年和2034年的市場規模預測,以及市場動態、關鍵促進因素、限制因素、機會、挑戰,並依組件、部署形式、技術、模式、應用和最終用戶進行了細分。報告還包括區域分析、競爭格局、公司概況、監管趨勢、併購、產品發布以及影響產業發展的最新技術進展。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會
  • 市場挑戰
  • 市場趨勢

第4章 主要考察

  • 人工智慧在乳房攝影診斷的技術進步
  • 主要產業趨勢(合併、收購、合作等)
  • 新產品發布:依主要公司分類
  • 這個市場的主要新創企業

第5章 2021-2034年全球人工智慧市場在乳房攝影影像領域的分析、洞察與預測

  • 市場分析、洞察與預測:依組件分類
    • 軟體
    • 服務
  • 市場分析、洞察與預測:依部署方式分類
    • 雲端
    • 現場
    • 混合
  • 市場分析、洞察與預測:依技術分類
    • 電腦視覺
    • 機器學習和深度學習
    • 自然語言處理(NLP)
    • 其他
  • 市場分析、洞察與預測:依模式分類
    • 乳房X光攝影/數位乳房斷層合成
    • 乳腺超音波檢查
    • 乳房核磁共振成像
    • 多重模式
    • 其他
  • 市場分析、洞察與預測:依應用領域分類
    • 癌症檢測和分診
    • 乳房密度評估
    • 風險分層
    • 工作流程優先排序
    • 報告和品質支持
    • 其他
  • 市場分析、洞察與預測:依最終用戶分類
    • 醫院和醫療保健系統
    • 診斷影像中心
    • 乳房檢查中心
    • 學術研究機構
    • 其他
  • 分析、洞察與預測:依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 2021-2034年北美乳房攝影人工智慧市場分析、洞察與預測

  • 國家
    • 美國
    • 加拿大

第7章 2021-2034年歐洲乳房攝影人工智慧市場分析、洞察與預測

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章 亞太地區乳房攝影人工智慧市場分析、洞察與預測(2021-2034年)

  • 國家
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章 2021-2034年拉丁美洲乳房攝影人工智慧市場分析、洞察與預測

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 2021-2034年中東與非洲乳房攝影人工智慧市場分析、洞察與預測

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 公司簡介
    • Hologic, Inc.
    • General Electric Company
    • RadNet, Inc.(DeepHealth)
    • Lunit Inc.
    • ScreenPoint Medical BV
    • CureMetrix, Inc.
    • Clairity
    • Whiterabbit
    • Densitas Inc.
    • Therapixel
Product Code: FBI117578

Growth Factors of AI in breast imaging Market

The global AI in breast imaging market is witnessing rapid growth due to the increasing adoption of artificial intelligence in breast cancer screening, growing demand for early disease detection, and rising pressure on radiologists to manage expanding imaging workloads. According to the report, the global AI in breast imaging market size was valued at USD 842.5 million in 2025. The market is projected to grow from USD 1,090.6 million in 2026 to USD 8,600.0 million by 2034, exhibiting a CAGR of 29.45% during the forecast period. North America dominated the market with a 41.99% share in 2025, driven by widespread adoption of digital mammography, AI-enabled diagnostic workflows, favorable regulatory approvals, and strong investments in healthcare technology.

AI in breast imaging comprises advanced software solutions and related services that support mammography, digital breast tomosynthesis (DBT), breast ultrasound, and MRI by improving lesion detection, breast density assessment, workflow prioritization, and reporting accuracy. Increasing breast cancer screening rates and the growing need for faster, more consistent diagnosis continue to fuel market expansion.

Market Definition and Scope

AI in breast imaging integrates machine learning, computer vision, and deep learning algorithms into breast imaging workflows to improve diagnostic accuracy and clinical efficiency. These AI-powered solutions assist radiologists in detecting suspicious lesions, evaluating dense breast tissue, prioritizing high-risk cases, and reducing false-negative results.

The market covers AI software, implementation and support services, cloud-based, on-premise, and hybrid deployment models, along with technologies such as computer vision, machine learning, and natural language processing. Applications include cancer detection & triage, breast density assessment, workflow prioritization, reporting support, and risk stratification across hospitals, diagnostic imaging centers, breast screening facilities, and research institutes.

Market Dynamics

Drivers

The increasing demand for early breast cancer detection is the primary driver of market growth. Rising breast cancer incidence, expanding national screening programs, and the need to detect cancers at earlier and more treatable stages are encouraging hospitals and imaging centers to adopt AI-assisted diagnostic tools. AI enhances radiologists' productivity by identifying subtle abnormalities, reducing missed diagnoses, and improving overall screening efficiency.

Trends

A major market trend is the growing adoption of AI-powered diagnostic technologies integrated into mammography, DBT, ultrasound, and MRI workflows. AI solutions are evolving beyond lesion detection to include breast density assessment, workflow optimization, and personalized risk prediction. Increasing regulatory approvals and successful real-world clinical studies are further accelerating adoption across healthcare systems.

Restraints

High implementation costs remain a major restraint for the market. Deploying AI requires investment in PACS/RIS integration, cloud infrastructure, cybersecurity, workflow redesign, software maintenance, and radiologist training. Limited reimbursement policies and high deployment costs continue to discourage adoption among smaller healthcare providers.

Opportunities

The expansion of AI-assisted 3D breast tomosynthesis (DBT) presents significant growth opportunities. As healthcare providers increasingly adopt DBT for superior breast tissue visualization, demand for AI tools capable of analyzing large volumes of 3D imaging data is rising rapidly. AI-assisted DBT improves diagnostic accuracy while reducing radiologists' reading time.

Challenges

Limited availability of high-quality annotated imaging datasets remains one of the industry's biggest challenges. Developing accurate AI algorithms requires extensive clinically validated mammography, ultrasound, MRI, and DBT datasets with expert annotations, making model development time-consuming and expensive.

Segmentation Analysis

By component, the software segment dominated the market in 2025 owing to increasing adoption of AI-powered diagnostic platforms integrated with PACS, cloud systems, and mammography workstations. Services are expected to experience steady growth as implementation and consulting demand increases.

By deployment, the cloud-based segment led the market due to its scalability, lower infrastructure investment, centralized software updates, and easier enterprise-wide deployment.

By technology, computer vision dominated the market as it plays a critical role in analyzing mammography, DBT, ultrasound, and MRI images for cancer detection and lesion identification.

By modality, mammography and digital breast tomosynthesis (DBT) accounted for the largest market share owing to their widespread use in routine breast cancer screening programs.

By application, cancer detection & triage remained the leading segment due to increasing clinical evidence demonstrating AI's ability to improve cancer detection rates while reducing radiologists' workload.

By end user, hospitals & health systems dominated the market because of their high imaging volumes, advanced digital infrastructure, and growing partnerships with AI solution providers.

Regional Insights

North America dominated the global AI in breast imaging market with a valuation of USD 353.8 million in 2025, supported by extensive adoption of AI-enabled mammography, digital breast tomosynthesis, advanced healthcare infrastructure, and favorable FDA approvals. Europe is expected to witness strong growth due to organized national screening programs and increasing regulatory acceptance of AI-enabled diagnostic technologies. Asia Pacific is projected to expand rapidly with growing breast cancer awareness, improving diagnostic infrastructure, and increasing investments in AI-based medical imaging across China, India, and Japan. Latin America and the Middle East & Africa are expected to experience steady growth as governments strengthen cancer screening programs and healthcare modernization initiatives.

Competitive Landscape

The global market is moderately fragmented, with companies focusing on regulatory approvals, AI innovation, workflow integration, and strategic partnerships. Major players include Hologic, Inc., GE HealthCare, Lunit Inc., RadNet (DeepHealth), ScreenPoint Medical B.V., CureMetrix, Clairity, Whiterabbit, Densitas Inc., and Therapixel. These companies continue expanding their AI portfolios through product innovation, cloud-based solutions, strategic collaborations, and clinical validation studies to strengthen their market positions.

Report Coverage

The report provides a comprehensive analysis of the global AI in breast imaging market, covering market size for 2025, 2026, and 2034, along with market dynamics, key drivers, restraints, opportunities, challenges, segmentation by component, deployment, technology, modality, application, and end user. It also includes regional analysis, competitive landscape, company profiles, regulatory developments, mergers & acquisitions, product launches, and recent technological advancements shaping the industry.

Conclusion

The global AI in breast imaging market is poised for exceptional growth, expanding from USD 842.5 million in 2025 to USD 1,090.6 million in 2026, and reaching USD 8,600.0 million by 2034. Rising breast cancer screening rates, increasing adoption of AI-powered diagnostic technologies, advancements in digital breast tomosynthesis, and growing demand for early disease detection will continue driving market expansion. Despite challenges related to implementation costs and data availability, continuous innovation, regulatory approvals, and broader clinical integration are expected to create substantial long-term opportunities for AI solution providers worldwide.

Segmentation By Component, Deployment, Technology, Modality, Application, End User, and Region

By Component * Software

  • Services

By Deployment * Cloud-Based

  • On-Premise
  • Hybrid

By Technology * Computer Vision

  • Machine Learning & Deep Learning
  • Natural Language Processing (NLP)
  • Others

By Modality * Mammography/DBT

  • Breast Ultrasound
  • Breast MRI
  • Multi-modality
  • Others

By Application * Cancer Detection & Triage

  • Breast Density Assessment
  • Risk Stratification
  • Workflow Prioritization
  • Reporting & Quality Support
  • Others

By End User * Hospitals & Health Systems

  • Diagnostic Imaging Centers
  • Breast Screening Centers
  • Academic & Research Institutes
  • Others

By Region * North America (By Component, Deployment, Technology, Modality, Application, End User, and Country)

    • U.S.
    • Canada
  • Europe (By Component, Deployment, Technology, Modality, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Component, Deployment, Technology, Modality, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Component, Deployment, Technology, Modality, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Component, Deployment, Technology, Modality, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Challenges
  • 3.5. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in AI in Breast Imaging
  • 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Start-ups in this market

5. Global AI in Breast Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Component
    • 5.1.1. Software
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Deployment
    • 5.2.1. Cloud-Based
    • 5.2.2. On-Premise
    • 5.2.3. Hybrid
  • 5.3. Market Analysis, Insights and Forecast - By Technology
    • 5.3.1. Computer Vision
    • 5.3.2. Machine Learning & Deep Learning
    • 5.3.3. Natural Language Processing (NLP)
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Modality
    • 5.4.1. Mammography/DBT
    • 5.4.2. Breast Ultrasound
    • 5.4.3. Breast MRI
    • 5.4.4. Multi-modality
    • 5.4.5. Others
  • 5.5. Market Analysis, Insights and Forecast - By Application
    • 5.5.1. Cancer Detection & Triage
    • 5.5.2. Breast Density Assessment
    • 5.5.3. Risk Stratification
    • 5.5.4. Workflow Prioritization
    • 5.5.5. Reporting & Quality Support
    • 5.5.6. Others
  • 5.6. Market Analysis, Insights and Forecast - By End User
    • 5.6.1. Hospitals & Health Systems
    • 5.6.2. Diagnostic Imaging Centers
    • 5.6.3. Breast Screening Centers
    • 5.6.4. Academic & Research Institutes
    • 5.6.5. Others
  • 5.7. Market Analysis, Insights and Forecast - Region
    • 5.7.1. North America
    • 5.7.2. Europe
    • 5.7.3. Asia Pacific
    • 5.7.4. Latin America
    • 5.7.5. Middle East & Africa

6. North America AI in Breast Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Component
    • 6.1.1. Software
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Deployment
    • 6.2.1. Cloud-Based
    • 6.2.2. On-Premise
    • 6.2.3. Hybrid
  • 6.3. Market Analysis, Insights and Forecast - By Technology
    • 6.3.1. Computer Vision
    • 6.3.2. Machine Learning & Deep Learning
    • 6.3.3. Natural Language Processing (NLP)
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Modality
    • 6.4.1. Mammography/DBT
    • 6.4.2. Breast Ultrasound
    • 6.4.3. Breast MRI
    • 6.4.4. Multi-modality
    • 6.4.5. Others
  • 6.5. Market Analysis, Insights and Forecast - By Application
    • 6.5.1. Cancer Detection & Triage
    • 6.5.2. Breast Density Assessment
    • 6.5.3. Risk Stratification
    • 6.5.4. Workflow Prioritization
    • 6.5.5. Reporting & Quality Support
    • 6.5.6. Others
  • 6.6. Market Analysis, Insights and Forecast - By End User
    • 6.6.1. Hospitals & Health Systems
    • 6.6.2. Diagnostic Imaging Centers
    • 6.6.3. Breast Screening Centers
    • 6.6.4. Academic & Research Institutes
    • 6.6.5. Others
  • 6.7. Market Analysis, Insights and Forecast - By Country
    • 6.7.1. U.S.
    • 6.7.2. Canada

7. Europe AI in Breast Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Component
    • 7.1.1. Software
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Deployment
    • 7.2.1. Cloud-Based
    • 7.2.2. On-Premise
    • 7.2.3. Hybrid
  • 7.3. Market Analysis, Insights and Forecast - By Technology
    • 7.3.1. Computer Vision
    • 7.3.2. Machine Learning & Deep Learning
    • 7.3.3. Natural Language Processing (NLP)
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Modality
    • 7.4.1. Mammography/DBT
    • 7.4.2. Breast Ultrasound
    • 7.4.3. Breast MRI
    • 7.4.4. Multi-modality
    • 7.4.5. Others
  • 7.5. Market Analysis, Insights and Forecast - By Application
    • 7.5.1. Cancer Detection & Triage
    • 7.5.2. Breast Density Assessment
    • 7.5.3. Risk Stratification
    • 7.5.4. Workflow Prioritization
    • 7.5.5. Reporting & Quality Support
    • 7.5.6. Others
  • 7.6. Market Analysis, Insights and Forecast - By End User
    • 7.6.1. Hospitals & Health Systems
    • 7.6.2. Diagnostic Imaging Centers
    • 7.6.3. Breast Screening Centers
    • 7.6.4. Academic & Research Institutes
    • 7.6.5. Others
  • 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.7.1. U.K.
    • 7.7.2. Germany
    • 7.7.3. France
    • 7.7.4. Italy
    • 7.7.5. Spain
    • 7.7.6. Scandinavia
    • 7.7.7. Rest of Europe

8. Asia Pacific AI in Breast Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Component
    • 8.1.1. Software
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Deployment
    • 8.2.1. Cloud-Based
    • 8.2.2. On-Premise
    • 8.2.3. Hybrid
  • 8.3. Market Analysis, Insights and Forecast - By Technology
    • 8.3.1. Computer Vision
    • 8.3.2. Machine Learning & Deep Learning
    • 8.3.3. Natural Language Processing (NLP)
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Modality
    • 8.4.1. Mammography/DBT
    • 8.4.2. Breast Ultrasound
    • 8.4.3. Breast MRI
    • 8.4.4. Multi-modality
    • 8.4.5. Others
  • 8.5. Market Analysis, Insights and Forecast - By Application
    • 8.5.1. Cancer Detection & Triage
    • 8.5.2. Breast Density Assessment
    • 8.5.3. Risk Stratification
    • 8.5.4. Workflow Prioritization
    • 8.5.5. Reporting & Quality Support
    • 8.5.6. Others
  • 8.6. Market Analysis, Insights and Forecast - By End User
    • 8.6.1. Hospitals & Health Systems
    • 8.6.2. Diagnostic Imaging Centers
    • 8.6.3. Breast Screening Centers
    • 8.6.4. Academic & Research Institutes
    • 8.6.5. Others
  • 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.7.1. China
    • 8.7.2. Japan
    • 8.7.3. India
    • 8.7.4. Australia
    • 8.7.5. Southeast Asia
    • 8.7.6. Rest of Asia Pacific

9. Latin America AI in Breast Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Component
    • 9.1.1. Software
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Deployment
    • 9.2.1. Cloud-Based
    • 9.2.2. On-Premise
    • 9.2.3. Hybrid
  • 9.3. Market Analysis, Insights and Forecast - By Technology
    • 9.3.1. Computer Vision
    • 9.3.2. Machine Learning & Deep Learning
    • 9.3.3. Natural Language Processing (NLP)
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Modality
    • 9.4.1. Mammography/DBT
    • 9.4.2. Breast Ultrasound
    • 9.4.3. Breast MRI
    • 9.4.4. Multi-modality
    • 9.4.5. Others
  • 9.5. Market Analysis, Insights and Forecast - By Application
    • 9.5.1. Cancer Detection & Triage
    • 9.5.2. Breast Density Assessment
    • 9.5.3. Risk Stratification
    • 9.5.4. Workflow Prioritization
    • 9.5.5. Reporting & Quality Support
    • 9.5.6. Others
  • 9.6. Market Analysis, Insights and Forecast - By End User
    • 9.6.1. Hospitals & Health Systems
    • 9.6.2. Diagnostic Imaging Centers
    • 9.6.3. Breast Screening Centers
    • 9.6.4. Academic & Research Institutes
    • 9.6.5. Others
  • 9.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.7.1. Brazil
    • 9.7.2. Mexico
    • 9.7.3. Rest of Latin America

10. Middle East & Africa AI in Breast Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Component
    • 10.1.1. Software
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Deployment
    • 10.2.1. Cloud-Based
    • 10.2.2. On-Premise
    • 10.2.3. Hybrid
  • 10.3. Market Analysis, Insights and Forecast - By Technology
    • 10.3.1. Computer Vision
    • 10.3.2. Machine Learning & Deep Learning
    • 10.3.3. Natural Language Processing (NLP)
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Modality
    • 10.4.1. Mammography/DBT
    • 10.4.2. Breast Ultrasound
    • 10.4.3. Breast MRI
    • 10.4.4. Multi-modality
    • 10.4.5. Others
  • 10.5. Market Analysis, Insights and Forecast - By Application
    • 10.5.1. Cancer Detection & Triage
    • 10.5.2. Breast Density Assessment
    • 10.5.3. Risk Stratification
    • 10.5.4. Workflow Prioritization
    • 10.5.5. Reporting & Quality Support
    • 10.5.6. Others
  • 10.6. Market Analysis, Insights and Forecast - By End User
    • 10.6.1. Hospitals & Health Systems
    • 10.6.2. Diagnostic Imaging Centers
    • 10.6.3. Breast Screening Centers
    • 10.6.4. Academic & Research Institutes
    • 10.6.5. Others
  • 10.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.7.1. GCC
    • 10.7.2. South Africa
    • 10.7.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Hologic, Inc.
    • 11.2.2. General Electric Company
    • 11.2.3. RadNet, Inc. (DeepHealth)
    • 11.2.4. Lunit Inc.
    • 11.2.5. ScreenPoint Medical B.V.
    • 11.2.6. CureMetrix, Inc.
    • 11.2.7. Clairity
    • 11.2.8. Whiterabbit
    • 11.2.9. Densitas Inc.
    • 11.2.10. Therapixel

List of Tables

  • Table 1: Global AI in Breast Imaging Market Revenue (USD Million) Forecast, By Component, 2021-2034
  • Table 2: Global AI in Breast Imaging Market Revenue (USD Million) Forecast, By Deployment, 2021-2034
  • Table 3: Global AI in Breast Imaging Market Revenue (USD Million) Forecast, By Technology, 2021-2034
  • Table 4: Global AI in Breast Imaging Market Revenue (USD Million) Forecast, By Modality, 2021-2034
  • Table 5: Global AI in Breast Imaging Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 6: Global AI in Breast Imaging Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 7: Global AI in Breast Imaging Market Revenue (USD Million) Forecast, By Region, 2021-2034
  • Table 8: North America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Component, 2021-2034
  • Table 9: North America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Deployment, 2021-2034
  • Table 10: North America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Technology, 2021-2034
  • Table 11: North America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Modality, 2021-2034
  • Table 12: North America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 13: North America AI in Breast Imaging Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 14: North America AI in Breast Imaging Market Revenue (USD Million) Forecast, by Country, 2021-2034
  • Table 15: Europe AI in Breast Imaging Market Revenue (USD Million) Forecast, By Component, 2021-2034
  • Table 16: Europe AI in Breast Imaging Market Revenue (USD Million) Forecast, By Deployment, 2021-2034
  • Table 17: Europe AI in Breast Imaging Market Revenue (USD Million) Forecast, By Technology, 2021-2034
  • Table 18: Europe AI in Breast Imaging Market Revenue (USD Million) Forecast, By Modality, 2021-2034
  • Table 19: Europe AI in Breast Imaging Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 20: Europe AI in Breast Imaging Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 21: Europe AI in Breast Imaging Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific AI in Breast Imaging Market Revenue (USD Million) Forecast, By Component, 2021-2034
  • Table 23: Asia Pacific AI in Breast Imaging Market Revenue (USD Million) Forecast, By Deployment, 2021-2034
  • Table 24: Asia Pacific AI in Breast Imaging Market Revenue (USD Million) Forecast, By Technology, 2021-2034
  • Table 25: Asia Pacific AI in Breast Imaging Market Revenue (USD Million) Forecast, By Modality, 2021-2034
  • Table 26: Asia Pacific AI in Breast Imaging Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 27: Asia Pacific AI in Breast Imaging Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 28: Asia Pacific AI in Breast Imaging Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 29: Latin America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Component, 2021-2034
  • Table 30: Latin America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Deployment, 2021-2034
  • Table 31: Latin America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Technology, 2021-2034
  • Table 32: Latin America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Modality, 2021-2034
  • Table 33: Latin America AI in Breast Imaging Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 34: Latin America AI in Breast Imaging Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 35: Latin America AI in Breast Imaging Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa AI in Breast Imaging Market Revenue (USD Million) Forecast, By Component, 2021-2034
  • Table 37: Middle East & Africa AI in Breast Imaging Market Revenue (USD Million) Forecast, By Deployment, 2021-2034
  • Table 38: Middle East & Africa AI in Breast Imaging Market Revenue (USD Million) Forecast, By Technology, 2021-2034
  • Table 39: Middle East & Africa AI in Breast Imaging Market Revenue (USD Million) Forecast, By Modality, 2021-2034
  • Table 40: Middle East & Africa AI in Breast Imaging Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 41: Middle East & Africa AI in Breast Imaging Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 42: Middle East & Africa AI in Breast Imaging Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global AI in Breast Imaging Market Revenue Breakdown (USD Million, %) By Region, 2025 & 2034
  • Figure 2: Global AI in Breast Imaging Market Value Share (%), By Component, 2025 & 2034
  • Figure 3: Global AI in Breast Imaging Market Value Share (%), By Deployment, 2025 & 2034
  • Figure 4: Global AI in Breast Imaging Market Value Share (%), By Technology, 2025 & 2034
  • Figure 5: Global AI in Breast Imaging Market Value Share (%), By Modality, 2025 & 2034
  • Figure 6: Global AI in Breast Imaging Market Value Share (%), By Application, 2025 & 2034
  • Figure 7: Global AI in Breast Imaging Market Value Share (%), By End User, 2025 & 2034
  • Figure 8: Global AI in Breast Imaging Market Value Share (%), By Region, 2025 & 2034
  • Figure 9: North America AI in Breast Imaging Market Value (USD Million), By Component, 2025 & 2034
  • Figure 10: North America AI in Breast Imaging Market Value Share (%), By Component, 2025
  • Figure 11: North America AI in Breast Imaging Market Value (USD Million), By Deployment, 2025 & 2034
  • Figure 12: North America AI in Breast Imaging Market Value Share (%), By Deployment, 2025
  • Figure 13: North America AI in Breast Imaging Market Value (USD Million), By Technology, 2025 & 2034
  • Figure 14: North America AI in Breast Imaging Market Value Share (%), By Technology, 2025
  • Figure 15: North America AI in Breast Imaging Market Value (USD Million), By Modality, 2025 & 2034
  • Figure 16: North America AI in Breast Imaging Market Value Share (%), By Modality, 2025
  • Figure 17: North America AI in Breast Imaging Market Value (USD Million), By Application, 2025 & 2034
  • Figure 18: North America AI in Breast Imaging Market Value Share (%), By Application, 2025
  • Figure 19: North America AI in Breast Imaging Market Value (USD Million), By End User, 2025 & 2034
  • Figure 20: North America AI in Breast Imaging Market Value Share (%), By End User, 2025
  • Figure 21: North America AI in Breast Imaging Market Value (USD Million), by Country, 2025 & 2034
  • Figure 22: North America AI in Breast Imaging Market Value Share (%), by Country, 2025
  • Figure 23: Europe AI in Breast Imaging Market Value (USD Million), By Component, 2025 & 2034
  • Figure 24: Europe AI in Breast Imaging Market Value Share (%), By Component, 2025
  • Figure 25: Europe AI in Breast Imaging Market Value (USD Million), By Deployment, 2025 & 2034
  • Figure 26: Europe AI in Breast Imaging Market Value Share (%), By Deployment, 2025
  • Figure 27: Europe AI in Breast Imaging Market Value (USD Million), By Technology, 2025 & 2034
  • Figure 28: Europe AI in Breast Imaging Market Value Share (%), By Technology, 2025
  • Figure 29: Europe AI in Breast Imaging Market Value (USD Million), By Modality, 2025 & 2034
  • Figure 30: Europe AI in Breast Imaging Market Value Share (%), By Modality, 2025
  • Figure 31: Europe AI in Breast Imaging Market Value (USD Million), By Application, 2025 & 2034
  • Figure 32: Europe AI in Breast Imaging Market Value Share (%), By Application, 2025
  • Figure 33: Europe AI in Breast Imaging Market Value (USD Million), By End User, 2025 & 2034
  • Figure 34: Europe AI in Breast Imaging Market Value Share (%), By End User, 2025
  • Figure 35: Europe AI in Breast Imaging Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 36: Europe AI in Breast Imaging Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 37: Asia Pacific AI in Breast Imaging Market Value (USD Million), By Component, 2025 & 2034
  • Figure 38: Asia Pacific AI in Breast Imaging Market Value Share (%), By Component, 2025
  • Figure 39: Asia Pacific AI in Breast Imaging Market Value (USD Million), By Deployment, 2025 & 2034
  • Figure 40: Asia Pacific AI in Breast Imaging Market Value Share (%), By Deployment, 2025
  • Figure 41: Asia Pacific AI in Breast Imaging Market Value (USD Million), By Technology, 2025 & 2034
  • Figure 42: Asia Pacific AI in Breast Imaging Market Value Share (%), By Technology, 2025
  • Figure 43: Asia Pacific AI in Breast Imaging Market Value (USD Million), By Modality, 2025 & 2034
  • Figure 44: Asia Pacific AI in Breast Imaging Market Value Share (%), By Modality, 2025
  • Figure 45: Asia Pacific AI in Breast Imaging Market Value (USD Million), By Application, 2025 & 2034
  • Figure 46: Asia Pacific AI in Breast Imaging Market Value Share (%), By Application, 2025
  • Figure 47: Asia Pacific AI in Breast Imaging Market Value (USD Million), By End User, 2025 & 2034
  • Figure 48: Asia Pacific AI in Breast Imaging Market Value Share (%), By End User, 2025
  • Figure 49: Asia Pacific AI in Breast Imaging Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 50: Asia Pacific AI in Breast Imaging Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 51: Latin America AI in Breast Imaging Market Value (USD Million), By Component, 2025 & 2034
  • Figure 52: Latin America AI in Breast Imaging Market Value Share (%), By Component, 2025
  • Figure 53: Latin America AI in Breast Imaging Market Value (USD Million), By Deployment, 2025 & 2034
  • Figure 54: Latin America AI in Breast Imaging Market Value Share (%), By Deployment, 2025
  • Figure 55: Latin America AI in Breast Imaging Market Value (USD Million), By Technology, 2025 & 2034
  • Figure 56: Latin America AI in Breast Imaging Market Value Share (%), By Technology, 2025
  • Figure 57: Latin America AI in Breast Imaging Market Value (USD Million), By Modality, 2025 & 2034
  • Figure 58: Latin America AI in Breast Imaging Market Value Share (%), By Modality, 2025
  • Figure 59: Latin America AI in Breast Imaging Market Value (USD Million), By Application, 2025 & 2034
  • Figure 60: Latin America AI in Breast Imaging Market Value Share (%), By Application, 2025
  • Figure 61: Latin America AI in Breast Imaging Market Value (USD Million), By End User, 2025 & 2034
  • Figure 62: Latin America AI in Breast Imaging Market Value Share (%), By End User, 2025
  • Figure 63: Latin America AI in Breast Imaging Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 64: Latin America AI in Breast Imaging Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 65: Middle East & Africa AI in Breast Imaging Market Value (USD Million), By Component, 2025 & 2034
  • Figure 66: Middle East & Africa AI in Breast Imaging Market Value Share (%), By Component, 2025
  • Figure 67: Middle East & Africa AI in Breast Imaging Market Value (USD Million), By Deployment, 2025 & 2034
  • Figure 68: Middle East & Africa AI in Breast Imaging Market Value Share (%), By Deployment, 2025
  • Figure 69: Middle East & Africa AI in Breast Imaging Market Value (USD Million), By Technology, 2025 & 2034
  • Figure 70: Middle East & Africa AI in Breast Imaging Market Value Share (%), By Technology, 2025
  • Figure 71: Middle East & Africa AI in Breast Imaging Market Value (USD Million), By Modality, 2025 & 2034
  • Figure 72: Middle East & Africa AI in Breast Imaging Market Value Share (%), By Modality, 2025
  • Figure 73: Middle East & Africa AI in Breast Imaging Market Value (USD Million), By Application, 2025 & 2034
  • Figure 74: Middle East & Africa AI in Breast Imaging Market Value Share (%), By Application, 2025
  • Figure 75: Middle East & Africa AI in Breast Imaging Market Value (USD Million), By End User, 2025 & 2034
  • Figure 76: Middle East & Africa AI in Breast Imaging Market Value Share (%), By End User, 2025
  • Figure 77: Middle East & Africa AI in Breast Imaging Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
  • Figure 78: Middle East & Africa AI in Breast Imaging Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 79: Global AI in Breast Imaging Market Share (%), by Company, 2025